![]() |
市場調查報告書
商品編碼
1788326
全球機器人內視鏡市場Robot-Assisted Endoscopes |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
到 2030 年,全球機器人內視鏡市場規模將達到 25 億美元
全球機器人輔助內視鏡市場規模預計在2024年為16億美元,到2030年將達到25億美元,2024年至2030年的複合年成長率為8.0%。醫院是本報告分析的細分市場之一,預計其複合年成長率將達到9.3%,到分析期結束時規模將達到17億美元。門診病人設施細分市場在分析期間內的複合年成長率預計為5.5%。
美國市場規模估計為 4.12 億美元,中國市場預計複合年成長率為 7.7%
美國機器人內視鏡市場規模預計在2024年達到4.12億美元。作為世界第二大經濟體,中國預計到2030年市場規模將達到3.966億美元,在2024-2030年的分析期間內,複合年成長率為7.7%。其他值得關注的區域市場包括日本和加拿大,預計在分析期間內,這兩個市場的複合年成長率分別為7.5%和6.7%。在歐洲,預計德國市場的複合年成長率約為6.3%。
全球機器人內視鏡市場-主要趨勢與促進因素摘要
機器人技術如何改變內視鏡檢查程序?
機器人技術與內視鏡的結合正在徹底改變微創診斷和治療程序,與傳統手動技術相比,它提供了更高的精確度、靈活性和控制力。機器人輔助內視鏡在胃腸 (GI) 內視鏡檢查、支氣管鏡檢查和神經外科內視鏡檢查等複雜程序中尤其有益,因為精確度至關重要。機器人系統透過多關節臂和人工智慧導航提供卓越的機動性,使外科醫生能夠輕鬆進入難以觸及的區域。觸覺回饋機制進一步提高了內視鏡介入的精確度和安全性。此外,遠端控制的機器人內視鏡減少了對操作員直接參與的需要,有可能在感染疾病爆發期間提高病患的安全性。即時影像處理、機器學習和人工智慧引導決策的進步意味著機器人輔助內視鏡正迅速成為內視鏡診斷和手術的黃金標準。
推動採用的關鍵應用有哪些?
機器人內視鏡已廣泛應用於多個醫療領域,尤其是胃腸病學、肺病學和腫瘤內科。在胃腸內視鏡檢查中,機器人系統用於先進的診斷和微創手術,例如息肉切除術、切片檢查和腫瘤切除術。機器人支氣管鏡檢查也越來越受歡迎,它可以精確導航肺部氣道,以便早期發現癌症並進行有針對性的切片檢查。神經外科也是一個新興領域,機器人神經科學用內視鏡正在改善對深部腦部病變的手術入路,同時最大限度地減少創傷。此外,泌尿系統和婦科中的機器人內視鏡手術由於能夠提高精細手術的精確度,其應用範圍正在擴大。隨著醫療服務提供者努力改善患者預後,對機器人內視鏡解決方案的需求正在迅速成長。
人工智慧和機器學習如何為機器人內視鏡提供動力?
人工智慧 (AI) 與機器學習 (ML) 在機器人輔助內視鏡檢查中的融合,正在徹底改變手術效率、影像解讀和決策。人工智慧影像增強技術提升了即時視覺化效果,從而能夠在胃腸道和肺部手術中更好地檢測和分類病變。機器學習演算法有助於自動息肉檢測、異常識別和即時切片檢查指導,從而減少人為錯誤並提高診斷準確性。此外,人工智慧運動控制和自主導航技術最佳化了機器人運動,提高了準確性並縮短了手術時間。遠端人工智慧輔助內視鏡檢查平台也發展迅速,能夠實現遠距專家會診和機器人輔助介入。這些技術進步使機器人輔助內視鏡檢查更加智慧、高效,在現代醫療環境中日益重要。
哪些因素推動了機器人內視鏡市場的成長?
機器人內視鏡市場的成長受到多種因素的推動,包括胃腸道和肺部疾病的日益普及、微創手術的日益普及以及人工智慧機器人技術的進步。對早期癌症檢測和精準切片檢查技術的需求正刺激機器人支氣管鏡和胃腸內視鏡的普及。遠端醫療和遠距手術援助的擴展也在市場發展中發揮關鍵作用。此外,對減少手術併發症、改善患者預後和提高手術效率的日益關注,正鼓勵醫療機構投資機器人內視鏡平台。隨著監管部門核准的增加和對下一代機器人內視鏡系統研究的加速,預計未來幾年市場將大幅成長。
部分
最終使用者(醫院、門診病人設施)
人工智慧整合
我們正在利用有效的專家內容和人工智慧工具來改變市場和競爭情報。
Global Industry Analysts 沒有查詢通用的 LLM 或特定產業的SLM,而是建立了一個來自世界各地專家的精選內容庫,其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。
關稅影響係數
全球產業分析師根據公司總部所在國家、製造地和進出口(成品和原始設備製造商)情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手,包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。
Global Robot-Assisted Endoscopes Market to Reach US$2.5 Billion by 2030
The global market for Robot-Assisted Endoscopes estimated at US$1.6 Billion in the year 2024, is expected to reach US$2.5 Billion by 2030, growing at a CAGR of 8.0% over the analysis period 2024-2030. Hospitals, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$1.7 Billion by the end of the analysis period. Growth in the Outpatient Facilities segment is estimated at 5.5% CAGR over the analysis period.
The U.S. Market is Estimated at US$412.0 Million While China is Forecast to Grow at 7.7% CAGR
The Robot-Assisted Endoscopes market in the U.S. is estimated at US$412.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$396.6 Million by the year 2030 trailing a CAGR of 7.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.5% and 6.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.3% CAGR.
Global Robot-Assisted Endoscope Market - Key Trends & Drivers Summarized
How Are Robotics Transforming Endoscopic Procedures?
The integration of robotics into endoscopy is revolutionizing minimally invasive diagnostics and therapeutic procedures, offering enhanced precision, flexibility, and control compared to conventional manual techniques. Robot-assisted endoscopy is particularly beneficial in complex procedures such as gastrointestinal (GI) endoscopy, bronchoscopy, and neurosurgical endoscopy, where precision is critical. Robotic systems provide superior maneuverability through articulating arms and AI-powered navigation, enabling surgeons to access hard-to-reach areas with greater ease. Haptic feedback mechanisms are further improving the accuracy and safety of endoscopic interventions. Additionally, remote-controlled robotic endoscopy is reducing the need for direct operator involvement, enabling enhanced patient safety during infectious disease outbreaks. With ongoing advancements in real-time imaging, machine learning, and AI-guided decision-making, robot-assisted endoscopy is poised to become the gold standard in endoscopic diagnostics and surgery.
What Are The Key Applications Driving Adoption?
Robot-assisted endoscopy is finding widespread adoption across multiple medical disciplines, with gastroenterology, pulmonology, and oncology being the leading fields of application. In GI endoscopy, robotic systems are being used for advanced diagnostics and minimally invasive procedures such as polypectomy, biopsy, and tumor ablation. Robotic bronchoscopy is also gaining traction, enabling the precise navigation of lung airways for early-stage cancer detection and targeted biopsy collection. Neurosurgery is another emerging area where robot-assisted neuro-endoscopy is improving surgical access to deep-seated brain lesions while minimizing trauma. Additionally, urological and gynecological robotic endoscopic procedures are seeing increasing adoption, as they offer enhanced precision in delicate surgeries. As healthcare providers strive to improve patient outcomes, the demand for robotic-assisted endoscopic solutions is rapidly growing.
How Are AI and Machine Learning Enhancing Robotic Endoscopy?
The integration of AI and machine learning (ML) in robotic-assisted endoscopy is revolutionizing procedural efficiency, image interpretation, and decision-making. AI-powered image enhancement is improving real-time visualization, enabling better lesion detection and classification in GI and pulmonary procedures. Machine learning algorithms are assisting in automated polyp detection, anomaly recognition, and real-time biopsy guidance, reducing human error and improving diagnostic accuracy. Additionally, AI-driven motion control and autonomous navigation are optimizing robotic movements, enhancing precision, and reducing procedural time. Remote AI-assisted endoscopy platforms are also gaining momentum, enabling expert consultations and robotic-assisted interventions from remote locations. These technological advancements are making robot-assisted endoscopy smarter, more efficient, and increasingly indispensable in modern healthcare settings.
What Factors Are Driving Growth in the Robot-Assisted Endoscope Market?
The growth in the robot-assisted endoscope market is driven by several factors, including the increasing prevalence of gastrointestinal and pulmonary diseases, rising adoption of minimally invasive procedures, and advancements in AI-powered robotic technologies. The demand for early cancer detection and precision biopsy techniques is fueling the adoption of robotic bronchoscopy and GI endoscopy. The expansion of telemedicine and remote surgical assistance is also playing a significant role in the market’s evolution. Additionally, the growing focus on reducing procedural complications, improving patient outcomes, and enhancing surgical efficiency is prompting healthcare facilities to invest in robotic-assisted endoscopic platforms. As regulatory approvals increase and research into next-generation robotic endoscopy systems accelerates, the market is expected to witness substantial growth in the coming years.
SCOPE OF STUDY:
The report analyzes the Robot-Assisted Endoscopes market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
End-Use (Hospitals, Outpatient Facilities)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
Select Competitors (Total 32 Featured) -
AI INTEGRATIONS
We're transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.